Clinical trials
Active, not recruiting Carcinoma, Ovarian Epithelial trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CanariaBio Inc. | 1 |
| Klus Pharma Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Center, Korea | 1 |
| Novartis Pharmaceuticals | 1 |
| Shanghai Gynecologic Oncology Group | 1 |
| pharmaand GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 7 |
| Fallopian Tube Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Anus Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.